Coya Therapeutics (COYA) Total Liabilities (2022 - 2025)
Coya Therapeutics (COYA) has disclosed Total Liabilities for 4 consecutive years, with $6.9 million as the latest value for Q4 2025.
- Quarterly Total Liabilities rose 45.12% to $6.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.9 million through Dec 2025, up 45.12% year-over-year, with the annual reading at $6.9 million for FY2025, 45.12% up from the prior year.
- Total Liabilities hit $6.9 million in Q4 2025 for Coya Therapeutics, up from $4.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $16.8 million in Q4 2022 to a low of -$2.0 million in Q1 2022.
- Historically, Total Liabilities has averaged $4.5 million across 4 years, with a median of $4.8 million in 2024.
- Biggest five-year swings in Total Liabilities: tumbled 66.49% in 2023 and later skyrocketed 294.84% in 2024.
- Year by year, Total Liabilities stood at $16.8 million in 2022, then crashed by 66.49% to $5.6 million in 2023, then dropped by 15.23% to $4.8 million in 2024, then soared by 45.12% to $6.9 million in 2025.
- Business Quant data shows Total Liabilities for COYA at $6.9 million in Q4 2025, $4.8 million in Q3 2025, and $5.1 million in Q2 2025.